Načítá se...
Can Propranalol Prevent Hepatocellular Carcinoma?
Beta-adrenergic signaling is involved in many processes that may contribute to cancer progression. In this issue of the journal (beginning on page XX), Nkontchou and colleagues report their retrospective observational finding that the beta-blocker propranolol was associated with a highly statistical...
Uloženo v:
| Hlavní autoři: | , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2012
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3415703/ https://ncbi.nlm.nih.gov/pubmed/22869451 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1940-6207.CAPR-12-0247 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|